Pediatrix Medical (MD) EBIAT (2009 - 2026)

Pediatrix Medical (MD) has 18 years of EBIAT data on file, last reported at $29.6 million in Q1 2026.

• Quarterly EBIAT rose 42.61% year-over-year to $29.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174.2 million (up 311.52% YoY) and the FY2025 annual result came in at $165.4 million, up 266.94% from the prior year.
• EBIAT eased to $29.6 million in Q1 2026 per MD's latest filing, from $33.7 million in the prior quarter.
• Across five years, EBIAT topped out at $71.7 million in Q3 2025 and bottomed at -$153.0 million in Q2 2024.
• The 5-year median for EBIAT is $27.1 million (2022), against an average of $5.9 million.
• The widest annual swing landed in 2024, when EBIAT tumbled 641.07%; it then soared 413.93% in 2025.
• Tracing MD's EBIAT over 5 years: stood at $29.7 million in 2022, then slumped by 519.0% to -$124.3 million in 2023, then soared by 124.52% to $30.5 million in 2024, then increased by 10.51% to $33.7 million in 2025, then slipped by 12.2% to $29.6 million in 2026.
• Per Business Quant, the three latest MD EBIAT figures stand at $29.6 million (Q1 2026), $33.7 million (Q4 2025), and $71.7 million (Q3 2025).

Peer Comparison